Stock Research for BIOAF

BIOAF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BIOAF Stock Chart & Research Data

The BIOAF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIOAF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BIOAF Due diligence Resources & Stock Charts

The BIOAF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BIOAF Detailed Price Forecast - CNN Money CNN View BIOAF Detailed Summary - Google Finance
Yahoo View BIOAF Detailed Summary - Yahoo! Finance Zacks View BIOAF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BIOAF Trends & Analysis - Trade-Ideas Barrons View BIOAF Major Holders - Barrons
NASDAQ View BIOAF Call Transcripts - NASDAQ Seeking View BIOAF Breaking News & Analysis - Seeking Alpha
Spotlight View BIOAF Annual Report - CompanySpotlight.com OTC Report View BIOAF OTC Short Report - OTCShortReport.com
TradeKing View BIOAF Fundamentals - TradeKing Charts View BIOAF SEC Filings - Bar Chart
WSJ View Historical Prices for BIOAF - The WSJ Morningstar View Performance/Total Return for BIOAF - Morningstar
MarketWatch View the Analyst Estimates for BIOAF - MarketWatch CNBC View the Earnings History for BIOAF - CNBC
StockMarketWatch View the BIOAF Earnings - StockMarketWatch MacroAxis View BIOAF Buy or Sell Recommendations - MacroAxis
Bullish View the BIOAF Bullish Patterns - American Bulls Short Pains View BIOAF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BIOAF Stock Mentions - StockTwits PennyStocks View BIOAF Stock Mentions - PennyStockTweets
Twitter View BIOAF Stock Mentions - Twitter Invest Hub View BIOAF Investment Forum News - Investor Hub
Yahoo View BIOAF Stock Mentions - Yahoo! Message Board Seeking Alpha View BIOAF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BIOAF - SECform4.com Insider Cow View Insider Transactions for BIOAF - Insider Cow
CNBC View BIOAF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BIOAF - OTC Markets
Yahoo View Insider Transactions for BIOAF - Yahoo! Finance NASDAQ View Institutional Holdings for BIOAF - NASDAQ


Stock Charts

FinViz View BIOAF Stock Insight & Charts - FinViz.com StockCharts View BIOAF Investment Charts - StockCharts.com
BarChart View BIOAF Stock Overview & Charts - BarChart Trading View View BIOAF User Generated Charts - Trading View




Latest Financial News for BIOAF


Bioasis Appoints Dr. Deborah Rathjen as President & Chief Executive Officer
Posted on Monday March 11, 2019

TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that its board of directors has appointed Dr. Deborah A. Rathjen as president and chief executive officer. Dr. Rathjen, who is a member of the board of directors and has served as executive chair since December 10, 2018, replaces Dr. Mark Day, who has left the company, effective immediately.


BiOasis: Fiscal 3Q Earnings Snapshot
Posted on Wednesday January 30, 2019

The Guilford, Connecticut-based company said it had a loss of less than 1 cent on a per-share basis. The biotech drug developer posted revenue of $926,000 in the period. The company's shares closed at ...


Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2018
Posted on Tuesday January 29, 2019

BIOASIS TECHNOLOGIES INC. , a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that it has filed its unaudited quarterly financial statements and management’s discussion ...


Bioasis Announces the Appointment of Christine Antalik as Chief Financial Officer
Posted on Wednesday January 09, 2019

OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced the appointment of Christine Antalik as chief financial officer.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.